SQUAWK/NEWS
Account
Account
Menu
Live NewsCategoriesequity

Roche Holding AG (RHHVF) News

Track canonical SquawkNews coverage tagged to RHHVF, Roche Holding AG. This hub brings together deduplicated headlines about otc markets otcqx, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol RHHVF Asset equity Sector Markets 90 days 1 Last 433.58 Updated Jul 02, 2026, 06:23 AM UTC Open live news feed
L Roche's Divarasib Shows Statistically Significant Progression-Free And Overall Survival Gains Versus Sotorasib Or Adagrasib In NSCLC Study Phase III (Krascendo 1) demonstrates best-in-class potential for patients with previously treated advanced KRAS G12C non-small cell lung cancer Divarasib showed clinically meaningful improvements in progression-free surv EQUITY | Jul 02, 2026, 06:23 AM UTC